MedicineEurope PMC
Ranked by formulaVerdict: NotableGenome-wide detection of genotype-environment interactions at biobank scale with fastGxE
Traditional genome-wide association studies have primarily focused on detecting main genotype effects, often overlooking genotype-environment interactions (GxE), which are essential for understanding context-specific…
Key numbers
- 126.49 times over existing approaches
VerdictWorth a reader's time today.
Abstract
Traditional genome-wide association studies have primarily focused on detecting main genotype effects, often overlooking genotype-environment interactions (GxE), which are essential for understanding context-specific genetic effects and refining disease etiology. Here we present fast genotype-environment interaction analysis (fastGxE), a scalable and effective genome-wide GxE method designed to identify genetic variants that interact with environmental factors to influence traits of interest. fastGxE controls for polygenic effects, polygenic interaction effects and noise heterogeneity; it remains robust to the number of environmental factors involved in GxE interactions; and it ensures scalability for genome-wide GxE analysis in large biobank studies, achieving speed improvements of 32.98-126.49 times over existing approaches. We illustrate the benefits of fastGxE through extensive simulations and an in-depth analysis of 32 physical traits and 67 blood biomarkers from the UK Biobank. In real-data applications, fastGxE identifies 7 genomic loci associated with physical traits, including 4 novel ones, and 18 genomic loci associated with blood biomarkers, 12 of which are novel. The new discoveries highlight the dynamic interplay between genetics and the environment, uncovering potentially clinically relevant pathways that could inform personalized interventions and treatment strategies.
The editor's rubric
- Leverage3 / 5
- A method or resource many groups across the field will adopt within a year.
- Magnitude3 / 5
- Large gain: roughly 2x, or a clear new state of the art on a hard, unsaturated problem.
- Evidence3 / 5
- Solid: multiple benchmarks or cohorts, ablations, fair baselines, released code or data.
- Novelty3 / 5
- A genuinely new approach to an open problem.
- Trajectory3 / 5
- A clear path to scale.
- Stakes3 / 5
- Meaningful benefit to many people within a few years.
Editor’s rationale
Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: method (we propose); breadth (many tasks); gains (x-fold); novelty (discovery); scale (scalable); stakes (prevention or cure, genetic disease).
How the score was computed
Desks place stronger verdicts first, then use this score to order work within the same verdict.
- Merit
- 6.0 / 10
- Adjusted merit
- 4.9 / 10
- Attention
- 0%
- Freshness
- 85%
- Citations0 (reference 20, via openalex, Oct 24, 2026, 05:48 UTC)